Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
about
Astrocytopathy in Balo's diseasePerfusion MRI: the five most frequently asked clinical questions.Lesions masquerading as acute stroke.A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia: doubtful CT, MRI, and bioptic findings: Case report and literature review.Immune mediated diseases and immune modulation in the neurocritical care unitPerformance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.Diagnostic imaging in acute disseminated encephalomyelitis.CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System.Coexistence of Multiple Sclerosis and Brain Tumor: An Uncommon Diagnostic Challenge.Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case reportUtility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.Structural and metabolic features of two different variants of multiple sclerosis: a PET/MRI study.Conventional and advanced magnetic resonance imaging in tumefactive demyelination.T2 hypointense rims and ring-enhancing lesions in MS.Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.Differentiation of tumefactive demyelinating lesions from high-grade gliomas with the use of diffusion tensor imaging.Progression of tumefactive demyelinating lesion in a child demonstrated with MRI.Development of a standardized MRI scoring tool for CNS demyelination in children.Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.Readout-segmented echo-planar imaging in diffusion-weighted imaging of the kidney: comparison with single-shot echo-planar imaging in image quality.Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms.
P2860
Q28308173-69E919A1-D740-46F9-A81C-47CF082C66FAQ30416198-32E1BD31-2CAC-4719-8FBA-EF752E3B1B0AQ30582481-A44246F1-1458-42A9-8E2F-B16C6E3C08FBQ31127156-A62CA78D-4EC0-4055-92B4-AD259B07B1C4Q35729575-9DDCAAAD-D4FF-4B94-A9C1-BF4FA40D9A9CQ36371802-3A1B4088-7325-42B7-9793-000B7C47D957Q37699430-C050EF59-0281-4AE7-8A53-C04582C6290CQ38705223-78EC2AB4-1B4B-4461-AF82-3D5E1D1D32FEQ41295485-638D2FF4-7A2F-4335-B68A-FE621CD787F6Q41608971-A3E4BD14-C359-4BD0-9347-534523F08BDAQ41944807-F600BAAF-7F06-4CD1-ABCF-FF478BAF30F4Q43981672-DF2BE979-62D4-47AD-888C-BF0C2F9A4FC2Q45356268-1E15CA66-7942-4223-ADF5-113C95636755Q45778451-67FE99F8-33A5-4125-920F-D5AF1F19B5EDQ46780251-030D4E16-E8FE-4787-81BC-9B87D3730FD9Q48100322-91393B4B-B19D-4076-9E7A-3E7866DC4758Q48155068-3FC56001-B551-49EA-8E93-A9150C7EBE2DQ48773626-0F1AA2AB-71F8-486F-AA75-C4F6F6330CB5Q50319812-C4D147E3-A12F-4496-9B45-1D991FB9E390Q50726292-E4692BA8-DB08-4540-BBAF-ADBE680C60BAQ52139773-F90684F9-5F7C-4AD7-8626-5EFE0D9F6297Q52985257-4FDDD4B0-AAF5-4BF1-BFC1-695EA0501D26Q55260453-286CB1B2-4773-473D-A036-718531565BDE
P2860
Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Characterization of tumefactiv ...... n-vivo proton MR spectroscopy.
@en
Characterization of tumefactiv ...... n-vivo proton MR spectroscopy.
@nl
type
label
Characterization of tumefactiv ...... n-vivo proton MR spectroscopy.
@en
Characterization of tumefactiv ...... n-vivo proton MR spectroscopy.
@nl
prefLabel
Characterization of tumefactiv ...... n-vivo proton MR spectroscopy.
@en
Characterization of tumefactiv ...... n-vivo proton MR spectroscopy.
@nl
P2093
P2860
P356
P1476
Characterization of tumefactiv ...... n-vivo proton MR spectroscopy.
@en
P2093
H S Malhotra
N Krishnani
P2860
P304
P356
10.1177/1352458508097922
P577
2009-02-01T00:00:00Z